These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2946005)

  • 1. [Mesoglycan and phlebopathy. A clinico-experimental contribution].
    Allegra C; Bonifacio M; Riccioni C; Tonelli V
    Minerva Med; 1986 Oct; 77(40):1887-92. PubMed ID: 2946005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic action of oral mesoglycan in the pharmacologic treatment of the varicose syndrome and its complications].
    Petruzzellis V; Velon A
    Minerva Med; 1985 Mar; 76(12):543-8. PubMed ID: 3157887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Instrumental evaluation of the effects of mesoglycan in venous disease patients. A prospective randomized double-blind study].
    de Donato G; Sangiuolo P
    Minerva Med; 1986 Oct; 77(41):1927-31. PubMed ID: 2946988
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
    Scondotto G; De Fabritiis A; Guastarobba A; Amato AC; Filippini M
    Minerva Med; 1984 Jul; 75(28-29):1733-8. PubMed ID: 6236381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease.
    Allegra C; Antignani PL
    Int Angiol; 2014 Oct; 33(5):407-18. PubMed ID: 24566500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of mesoglycan in the treatment of venous diseases of surgical importance].
    Cianfanelli G; Borreani B; Zepponi E; Brizio L; Colotto P; Toniutti F
    Minerva Med; 1986 Oct; 77(41):1943-4. PubMed ID: 2946991
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of extract of Ruscus aculeatus in venous disease in the lower limbs.
    Cappelli R; Nicora M; Di Perri T
    Drugs Exp Clin Res; 1988; 14(4):277-83. PubMed ID: 3048951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of internally effective venous drugs].
    Friederich HC; Vogelsberg H; Neiss A
    Z Hautkr; 1978 Jun; 53(11):369-74. PubMed ID: 351993
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulodexide: it is time for a program against chronic venous disease.
    Roztocil K; Antignani PL
    Int Angiol; 2014 Jun; 33(3):209-11. PubMed ID: 24936530
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of acute and chronic venous pathology of the extremities. Effect of mesoglycan in a case study of 50 patients].
    Florio A; Rosati V; Cioffi G
    Minerva Med; 1986 Oct; 77(41):1933-5. PubMed ID: 2946989
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of mesoglycan sulfate in primary varices and post-thrombotic syndrome. An evaluation using strain gauge plethysmography].
    Cospite M; Milio G; Ferrara F
    Minerva Med; 1986 Oct; 77(40):1893-8. PubMed ID: 2946006
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mesoglycan in acute and chronic venous insufficiency of the legs].
    Sangrigoli V; Carrà G; Lazzara N; Micale F; Puleo MG; Bonaccorsi R
    Clin Ter; 1989 May; 129(3):207-9. PubMed ID: 2527115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Centella asiatica extract in venous disorders of the lower limbs. Comparative clinico-instrumental studies with a placebo].
    Allegra C; Pollari G; Criscuolo A; Bonifacio M; Tabassi D
    Clin Ter; 1981 Dec; 99(5):507-13. PubMed ID: 7037273
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of venous diseases using Flavan].
    Feine-Haake G
    Z Allgemeinmed; 1975 Jun; 51(18):839. PubMed ID: 1224652
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of our experience in the use of mesoglycan in the therapy of acute and chronic venous diseases of the legs].
    Mangoni N; Righi D; Lucente E; Tonarelli AP; Lucarelli F; Borgioli F; Nuzzaci G
    Minerva Med; 1986 Oct; 77(41):1903-8. PubMed ID: 2946983
    [No Abstract]   [Full Text] [Related]  

  • 17. Constriction of varicose veins and improvement of venous pumping by dihydroergotamine.
    Partsch H; Mostbeck A
    Vasa; 1985; 14(1):74-80. PubMed ID: 3976280
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with a vasoprotective drug in the treatment of venous problems of the lower limbs].
    De Caprio M; Vinci L; Giumetti D; Colitta G
    Clin Ter; 1982 Jun; 101(5):497-508. PubMed ID: 6897029
    [No Abstract]   [Full Text] [Related]  

  • 19. [Conservative and surgical measures in phlebologic consulatation. Report on the potassium-neutral venous diuretic Dehydro-sanol-tri].
    Wissniowski T; Harlin-Wissniowski A
    Fortschr Med; 1974 Oct; 92(28):1132-7. PubMed ID: 4616896
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of painful venous congestion using a veno-diuretic agent].
    Sedlmaier R
    Med Welt; 1974 Mar; 25(13):563-64. PubMed ID: 4827978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.